Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Adipex P)
1,413 results
  • StatPearls [BOOK]
  • BOOKStatPearls Publishing: Treasure Island (FL)
  • Johnson Donavon B. DB Ross University Bhimji Steve S. SS Un of Toronto
  • Phentermine and extended-release (ER) topiramate have been used separately in a variety of ways. Phentermine was first introduced in 1959 as part of an anti-obesity combination drug. Topiramate was d...
  • Pharmacotherapy for obesity in individuals with type 2 diabetes. [Review]
  • EOExpert Opin Pharmacother 2018; 19(3):223-231
  • Chukir T, Shukla AP, … Aronne LJ
  • Type 2 diabetes (T2DM) is associated with significant morbidity and mortality. Obesity is one of the main risk factors for T2DM and its management requires a multidisciplinary approach, which may inc...
  • Obesity: Pathophysiology and Management. [Review]
  • JACCJ Am Coll Cardiol 2018 Jan 02; 71(1):69-84
  • Gadde KM, Martin CK, … Heymsfield SB
  • Obesity continues to be among the top health concerns across the globe. Despite our failure to contain the high prevalence of obesity, we now have a better understanding of its pathophysiology, and h...
  • Efficacy of adjuvant weight loss medication after bariatric surgery. [Journal Article]
  • SOSurg Obes Relat Dis 2018; 14(1):93-98
  • Nor Hanipah Z, Nasr EC, … Cetin D
  • CONCLUSIONS: Adjuvant weight loss medications halted weight regain in patients who underwent bariatric surgery. More than one third achieved>5% weight loss with the addition of weight loss medication. The observed response was significantly better in gastric bypass and gastric banding patients compared with sleeve gastrectomy patients. Furthermore, adjuvant pharmacotherapy was more effective in patients with higher body mass index. Given the low risk of medications compared with revisional surgery, it can be a reasonable option in the appropriate patients. Further studies are necessary to determine the optimal medication and timing of adjuvant pharmacotherapy after bariatric surgery.
New Search Next